Abstract
The central nervous system (CNS) is refractive to many aspects of the immune system primarily due to its limited ability to repair damage induced by the cytopathic mechanisms deployed by most immune cells. A primary obstacle to CNS inflammation is the blood-brain-barrier (BBB), which limits entry of immune cells into the CNS. To pass the BBB, inflammatory cells release matrix metalloproteinases (MMPs); a growing family of proteases with overlapping substrate specificities for components of the extracellular matrix (reveiwed by Kieseier et al. 1999). MMPs break down the extracellular matrix surrounding the endothelial layer of BBB thereby permitting peripheral immune cells to traverse the BBB and migrate through the parenchyma of the CNS in response to inflammatory signals. To limit potential damage resulting from infiltration of inflammatory cells, MMP activity is tightly regulated at both the level of gene expression and proenzyme activation as well as by expression of a second gene family, the tissue inhibitors of MMPs (TIMPs). TIMPs act as competitive inhibitors for the active sites of MMPs and thus limit inflammatory infiltrates.
Chapter PDF
Similar content being viewed by others
Keywords
- RNAse Protection Assay
- Mononuclear Cell Infiltration
- Immune Cell Infiltration
- naIve Mouse
- Mouse Hepatitis Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Esparza, J., C. Vilardell, J. Calvo, M. Juan, J. Vives, A. Urbano-Marquez, J. Yague and M. C. Cid. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinate expression of gelatinase A (MMP-2) and its activator MTl-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signalling pathways. Blood. 1999. 94:2754–2766
Faris B., P. Mozzicato, R. Ferrera, M. Glembourtt, P. Toselli and C. Franzblau. Collagen of Brain Microvessel Preparations. Mircovasc. Res. 1982. 23:171–179
Fleming, J. O., M. Trousdale, F. E. Zactarim, S. A. Stohlman and L. P. Weiner. Pathogenicity of antigenic variants of murine Coronavirus JHM selected with mAb. J. Virol. 1986. 58:869–875.
Giraudon, P., R. Szymocha, S. Buart, A. Bernard, L. Cartier, M. F. Belin and H. Akaoka. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J. Immunol. 2000. 164:2718–2727.
Goetzl EJ. Banda MJ. Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 1996. 156:1–4.
Gomis-Ruth, F.-X., K. Maskos, M. Betz, A. Bergner, R. Huber, K. Suszuki, N. Yoshida, H. Nagase, K. Brew, G. P. Bourenkov, H. Bartunik and W. Bode. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 1997. 389:77–81.
Kieseier, B. C., T. Seifert, G. Giovannoni and H. P. Hartung. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology. 1999. 53:20–25.
Maeda, A. and R. A. Sobel. Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions. J. Neuropath. Exp. Neuro. 1996. 55:300–309.
Ozenci V., L. Rinaldi, N. Teleshova, D. Matusevicius, P. Kivisakk, M. Kouwenhoven and H. Link. Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun. 1999. 12:297–303.
Pagenstecher, A., A. K. Stalder and I. L. Campbell. RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs. J. Immunol. Meth. 1997. 206:1–9.
Pagenstecher, A., A. K. Stalder, C. L. Kincaid, S. D. Shapiro, I. L. Campbell. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Path. 1998. 152:729–741.
Shapiro, S. D. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb & Haemo. 1999. 82:846–849.
Williamson, J. S. P., K. Sykes and S. A. Stohlman. Characterization of brain infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 1991. 32:199–207.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zhou, J., Stohlman, S.A., Marten, N.W., Hinton, D.R. (2001). Regulation of Matrix Metalloproteinase (MMP) and Tissue Inhibitor of Matrix Metalloproteinase (TIMP) Genes During JHMV Infection of the Central Nervous System. In: Lavi, E., Weiss, S.R., Hingley, S.T. (eds) The Nidoviruses. Advances in Experimental Medicine and Biology, vol 494. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1325-4_49
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1325-4_49
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5498-7
Online ISBN: 978-1-4615-1325-4
eBook Packages: Springer Book Archive